ACM
PODD icon

Atika Capital Management’s Insulet PODD Stock Holding History

Atika Capital Management’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-28,000
Closed -$2.22M – 91
2018
Q4 		$2.22M Buy
+28,000
New +$2.37M 0.65% 57

Other funds holding PODD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

Atika Capital Management's PODD Position: Q1 2022 in Review

Atika Capital Management sold out of Insulet (PODD) in Q1 2022, closing a stake of 43,785 shares — an estimated $11.7M sold.

Atika Capital Management first reported a position in PODD in Q3 2014 and held it in 13 quarters. The position peaked at $18.1M in Q2 2021. 483 funds tracked by Wall St. Rank hold PODD as of Q1 2022.

  • Atika Capital Management reported no remaining Insulet position as of Q1 2022 after selling out during the quarter.
  • Atika Capital Management sold 43,785 Insulet shares in Q1 2022, an estimated $11.7M.
  • Atika Capital Management first reported a position in Insulet in Q3 2014 and held it in 13 quarters.
  • Atika Capital Management's Insulet position peaked at $18.1M in Q2 2021.
  • 483 funds tracked by Wall St. Rank held Insulet as of Q1 2022.

Based on Atika Capital Management's 13F filing for Q1 2022, filed 13 May 2022.